Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
A preliminary announcement of a new in vitro blood test for cancer by Field and Caspary appeared in the Lancet of 26 December 1970. The test depends on sensitization of the patient's lymphocytes to a common antigen apparently present in human tumours. We now offer independent confirmation of these findings, together with methods for improving the test towards its future clinical use.
D000818:Animals; D000951:Antigens, Neoplasm; D004586:Electrophoresis; D006168:Guinea Pigs; D006801:Humans; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology*; D009369:Neoplasms / Q000175:diagnosis* / Q000276:immunology; D011829:Radiation Dosage; D013997:Time Factors
D000951:Antigens, Neoplasm